Horizon’s Rayos and Amarin’s Vascepa Approved by FDA

The US Food and Drug Administration (FDA) have announced that they have approved Amarin Corp’s heart pill, Vascepa, and Horizon Pharma’s anti-inflammatory, Rayos. The FDA approved Vascepa (icosapent ethyl), formerly known as AMR101, as an addition to diet to reduce triglyceride (levels in adult patients with severe hypertriglyceridemia).  Triglycerides is a blood fat that contributes

Continue Reading